100 related articles for article (PubMed ID: 26732125)
1. Evaluation of serum markers in the LRF CLL4 trial: β2-microglobulin but not serum free light chains, is an independent marker of overall survival.
Pratt G; Thomas P; Marden N; Alexander D; Davis Z; Hussey D; Parry H; Harding S; Catovsky D; Begley J; Oscier D
Leuk Lymphoma; 2016 Oct; 57(10):2342-50. PubMed ID: 26732125
[TBL] [Abstract][Full Text] [Related]
2. Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia.
Pratt G; Harding S; Holder R; Fegan C; Pepper C; Oscier D; Gardiner A; Bradwell AR; Mead G
Br J Haematol; 2009 Jan; 144(2):217-22. PubMed ID: 19016722
[TBL] [Abstract][Full Text] [Related]
3. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.
Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B
Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957
[TBL] [Abstract][Full Text] [Related]
4. Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors.
Xu W; Cao X; Miao KR; Qiao C; Wu YJ; Liu Q; Fan L; Li JY
Int J Hematol; 2009 Sep; 90(2):205-211. PubMed ID: 19629630
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Factors for Chronic Lymphocytic Leukemia.
Chen C; Puvvada S
Curr Hematol Malig Rep; 2016 Feb; 11(1):37-42. PubMed ID: 26748932
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation.
Oscier D; Wade R; Davis Z; Morilla A; Best G; Richards S; Else M; Matutes E; Catovsky D;
Haematologica; 2010 Oct; 95(10):1705-12. PubMed ID: 20511662
[TBL] [Abstract][Full Text] [Related]
7. The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia.
Morabito F; De Filippi R; Laurenti L; Zirlik K; Recchia AG; Gentile M; Morelli E; Vigna E; Gigliotti V; Calemma R; Amoroso B; Neri A; Cutrona G; Ferrarini M; Molica S; Del Poeta G; Tripodo C; Pinto A
Blood; 2011 Dec; 118(24):6353-61. PubMed ID: 21998207
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic significance of lactate dehydrogenase and beta2-microglobulin in chronic lymphocytic leukemia].
Shen QD; Xu W; Yu H; Li L; Zhang SJ; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1305-8. PubMed ID: 18088490
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients.
García de Veas Silva JL; Bermudo Guitarte C; Menéndez Valladares P; Rojas Noboa JC; Kestler K; Duro Millán R
PLoS One; 2016; 11(11):e0166841. PubMed ID: 27893836
[TBL] [Abstract][Full Text] [Related]
10. The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial.
Oscier D; Else M; Matutes E; Morilla R; Strefford JC; Catovsky D
Br J Haematol; 2016 Sep; 174(5):767-75. PubMed ID: 27151266
[TBL] [Abstract][Full Text] [Related]
11. The long-term outcome of patients in the LRF CLL4 trial: the effect of salvage treatment and biological markers in those surviving 10 years.
Else M; Wade R; Oscier D; Catovsky D
Br J Haematol; 2016 Jan; 172(2):228-37. PubMed ID: 26457986
[TBL] [Abstract][Full Text] [Related]
12. Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia.
Pflug N; Bahlo J; Shanafelt TD; Eichhorst BF; Bergmann MA; Elter T; Bauer K; Malchau G; Rabe KG; Stilgenbauer S; Döhner H; Jäger U; Eckart MJ; Hopfinger G; Busch R; Fink AM; Wendtner CM; Fischer K; Kay NE; Hallek M
Blood; 2014 Jul; 124(1):49-62. PubMed ID: 24797299
[TBL] [Abstract][Full Text] [Related]
13. Serum carbohydrate antigen 125 is not an independent prognostic factor in patients with chronic lymphocytic leukemia.
Zou ZJ; Fan L; Wang L; Zhang R; Zhang LN; Yang S; Li JY; Xu W
Cancer Biomark; 2012; 12(4):169-76. PubMed ID: 23568007
[TBL] [Abstract][Full Text] [Related]
14. Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and beta2-microglobulin in B-cell chronic lymphocytic leukemia.
Molica S; Levato D; Cascavilla N; Levato L; Musto P
Eur J Haematol; 1999 Feb; 62(2):117-22. PubMed ID: 10052715
[TBL] [Abstract][Full Text] [Related]
15. The study of different chromosomal aberrations, CD38 and ZAP-70 in chronic lymphocytic leukemia patients.
Hassab AH; Elbordiny MM; Elghandour AH; Sorour AF; Swelem RS
Egypt J Immunol; 2011; 18(2):77-93. PubMed ID: 23082473
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of patients' sex in chronic lymphocytic leukemia.
Catovsky D; Wade R; Else M
Haematologica; 2014 Jun; 99(6):1088-94. PubMed ID: 24658818
[TBL] [Abstract][Full Text] [Related]
17. Pathology consultation on evaluating prognosis in incidental monoclonal lymphocytosis and chronic lymphocytic leukemia.
Siddon AJ; Rinder HM;
Am J Clin Pathol; 2013 Jun; 139(6):708-12. PubMed ID: 23690112
[TBL] [Abstract][Full Text] [Related]
18. A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).
Molica S; Giannarelli D; Levato L; Mirabelli R; Gentile M; Lentini M; Morabito F
Int J Hematol; 2014 Sep; 100(3):290-5. PubMed ID: 25064370
[TBL] [Abstract][Full Text] [Related]
19. Serum tumor necrosis factor-α and interleukin-10 levels as markers to predict outcome of patients with chronic lymphocytic leukemia in different risk groups defined by the IGHV mutation status.
Lech-Maranda E; Grzybowska-Izydorczyk O; Wyka K; Mlynarski W; Borowiec M; Antosik K; Cebula-Obrzut B; Makuch-Lasica H; Nowak G; Klimkiewicz-Wojciechowska G; Wawrzyniak E; Bilinski P; Robak T; Warzocha K
Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):477-86. PubMed ID: 22945689
[TBL] [Abstract][Full Text] [Related]
20. ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia.
Dürig J; Nückel H; Cremer M; Führer A; Halfmeyer K; Fandrey J; Möröy T; Klein-Hitpass L; Dührsen U
Leukemia; 2003 Dec; 17(12):2426-34. PubMed ID: 14523469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
